Robert Hast

3.1k total citations
99 papers, 2.0k citations indexed

About

Robert Hast is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Robert Hast has authored 99 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 26 papers in Genetics and 18 papers in Molecular Biology. Recurrent topics in Robert Hast's work include Acute Myeloid Leukemia Research (50 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Hematological disorders and diagnostics (13 papers). Robert Hast is often cited by papers focused on Acute Myeloid Leukemia Research (50 papers), Hematopoietic Stem Cell Transplantation (14 papers) and Hematological disorders and diagnostics (13 papers). Robert Hast collaborates with scholars based in Sweden, United Kingdom and Denmark. Robert Hast's co-authors include Eva Hellström‐Lindberg, Ingrid Arvidsson, Per Bernell, Björn Jacobsson, Lars Nilsson, Sten Eirik W. Jacobsen, Ingbritt Åstrand‐Grundström, Peter Reizenstein, Magnus Björkholm and Anna Porwit and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Robert Hast

95 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Hast Sweden 23 1.4k 587 461 345 317 99 2.0k
H. L. Haak Netherlands 17 1.1k 0.8× 534 0.9× 320 0.7× 283 0.8× 188 0.6× 42 1.8k
Emmanuel C. Besa United States 23 1.0k 0.7× 693 1.2× 425 0.9× 167 0.5× 481 1.5× 68 1.7k
A. Heyll Germany 22 1.2k 0.8× 371 0.6× 412 0.9× 331 1.0× 196 0.6× 65 1.7k
SI Bearman United States 17 1.4k 0.9× 378 0.6× 392 0.9× 509 1.5× 390 1.2× 35 2.3k
Eeva Juvonen Finland 30 1.6k 1.1× 1.1k 1.8× 524 1.1× 619 1.8× 440 1.4× 83 2.8k
Ichiro Tsukimoto Japan 26 1.6k 1.1× 320 0.5× 397 0.9× 519 1.5× 330 1.0× 78 2.2k
JM Rappeport United States 15 1.4k 1.0× 390 0.7× 172 0.4× 471 1.4× 436 1.4× 24 1.9k
Éliane Duchayne France 18 701 0.5× 470 0.8× 312 0.7× 241 0.7× 204 0.6× 38 1.2k
Aruna Raghavachar Germany 22 1.5k 1.0× 495 0.8× 357 0.8× 497 1.4× 516 1.6× 55 2.1k
C Rosenfeld United States 22 1.8k 1.2× 463 0.8× 1.5k 3.4× 497 1.4× 329 1.0× 61 3.0k

Countries citing papers authored by Robert Hast

Since Specialization
Citations

This map shows the geographic impact of Robert Hast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hast more than expected).

Fields of papers citing papers by Robert Hast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Hast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hast. The network helps show where Robert Hast may publish in the future.

Co-authorship network of co-authors of Robert Hast

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Hast. A scholar is included among the top collaborators of Robert Hast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Hast. Robert Hast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hast, Robert, et al.. (2014). Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes. European Journal of Oncology Nursing. 19(2). 99–106. 20 indexed citations
2.
Jädersten, Martin, Leonie Saft, Alexander Smith, et al.. (2011). TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression. Journal of Clinical Oncology. 29(15). 1971–1979. 332 indexed citations
3.
Mejhert, Märit, Robert Hast, Bengt Sandstedt, & I Janczewska. (2011). Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract. BMJ Case Reports. 2011. bcr0320114007–bcr0320114007. 2 indexed citations
4.
Janczewska, I, et al.. (2004). Primary AL-amyloidosis, ulcerative colitis and collagenous colitis in a 57-year-old woman: a case study. Scandinavian Journal of Gastroenterology. 39(12). 1306–1309. 16 indexed citations
5.
Åstrand‐Grundström, Ingbritt, Kristina Anderson, Ingrid Arvidsson, et al.. (2001). Involvement and intrinsic deficiencies of hematopoietic stem cells in MDS patients with trisomy 8. Blood. 98(11). 354–354. 2 indexed citations
6.
Hast, Robert, et al.. (1999). Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes. Leukemia Research. 23(6). 579–584. 13 indexed citations
7.
Hast, Robert, et al.. (1999). Successful Treatment with Fludarabine in Two Cases of Angioimmunoblastic Lymphadenopathy with Dysproteinemia. Leukemia & lymphoma. 34(5-6). 597–601. 19 indexed citations
8.
Bernell, Per, Ingrid Arvidsson, Björn Jacobsson, & Robert Hast. (1996). Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia. British Journal of Haematology. 95(4). 666–672. 25 indexed citations
9.
Bernell, Per, et al.. (1996). A sequential erythropoietin and GM-CSF schedule offers clinical benefits in the treatment of anaemia in myelodysplastic syndromes. Leukemia Research. 20(8). 693–699. 16 indexed citations
10.
Widell, Susanne, Gert Auer, Robert Hast, & Peter Reizenstein. (1993). Variation in DNA content of immature normal bone marrow cells. American Journal of Hematology. 43(4). 291–294. 2 indexed citations
11.
Hast, Robert & Susanne Widell. (1992). Dysplastic peripheral blood polymorphs link acute myeloblastic leukaemia in elderly to the mvelodvsdastic Syndromes. European Journal Of Haematology. 48(3). 163–167. 7 indexed citations
12.
Hast, Robert & Per Bernell. (1992). Minimal diagnostic criteria for the myelodysplastic syndrome in clinical practice. Leukemia Research. 16(1). 8–9. 1 indexed citations
13.
Simonsson, Bengt, Gunnar Öberg, Gösta Gahrton, et al.. (1992). Intensive Treatment in order to Minimize the Ph-Positive Clone in Chronic Myelogenic Leukemia. Leukemia & lymphoma. 7(sup1). 55–57. 15 indexed citations
14.
Hast, Robert, et al.. (1989). Absent clinical effects of retinoic acid and isoretinoin treatment in the myelodysplastic syndrome. Hematological Oncology. 7(4). 297–301. 7 indexed citations
15.
Porwit, Anna, et al.. (1987). Cyclosporine A treatment in four cases of aplastic anemia. Annals of Hematology. 54(2). 73–78. 8 indexed citations
16.
Stenke, Leif, Robert Hast, & Peter Reizenstein. (1987). Treatment of poor prognosis acute myeloid leukemia with aggressive and non-aggressive chemotherapy.. PubMed. 6(2 Suppl). 723–4. 1 indexed citations
17.
Hast, Robert, Thomas D. Miale, Jan Westin, et al.. (1983). Hereditary Ring Sideroblastic Anaemia and Christmas Disease in a Swedish Family. Scandinavian Journal of Haematology. 30(5). 444–450. 3 indexed citations
18.
Engstedt, L., Robert Hast, G. Holm, et al.. (1982). Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 9(2). 89–92. 6 indexed citations
19.
Hast, Robert & Peter Reizenstein. (1981). Sideroblastic anemia and development of leukemia. Annals of Hematology. 42(4). 203–207. 13 indexed citations
20.
Hast, Robert, L. Engstedt, Sean C. Jameson, et al.. (1978). Oxymetholone treatment in myelofibrosis. Annals of Hematology. 37(1). 19–26. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. L. Haak Breakdown of academic impact, for papers by Emmanuel C. Besa Breakdown of academic impact, for papers by A. Heyll Breakdown of academic impact, for papers by SI Bearman Breakdown of academic impact, for papers by Eeva Juvonen Breakdown of academic impact, for papers by Ichiro Tsukimoto Breakdown of academic impact, for papers by JM Rappeport Breakdown of academic impact, for papers by Éliane Duchayne Breakdown of academic impact, for papers by Aruna Raghavachar Breakdown of academic impact, for papers by C Rosenfeld
Rankless by CCL
2026